[Organic mixed affective disorder].
Sasaki M.
Ryoikibetsu Shokogun Shirizu. 2003;(40):180-3.
Pseudodementia.
Fisman M.
Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):481-4. doi: 10.1016/0278-5846(85)90005-3.
Mixed organic brain syndrome as a manifestation of systemic mastocytosis.
Rogers MP, Bloomingdale K, Murawski BJ, Soter NA, Reich P, Austen KF.
Psychosom Med. 1986 Jul-Aug;48(6):437-47. doi: 10.1097/00006842-198607000-00006.
State and trait markers to define the continuum of affective disorders.
Stoyanov D.
J Affect Disord. 2025 Mar 1;372:37-39. doi: 10.1016/j.jad.2024.11.078. Epub 2024 Nov 29.
The Addenbrooke's cognitive examination (ACE) in the differential diagnosis of early dementias versus affective disorder.
Dudas RB, Berrios GE, Hodges JR.
Am J Geriatr Psychiatry. 2005 Mar;13(3):218-26. doi: 10.1176/appi.ajgp.13.3.218.
[Diagnostics and early recognition of bipolar disorders].
Schäfer M, Correll CU.
Nervenarzt. 2020 Mar;91(3):207-215. doi: 10.1007/s00115-020-00881-5.
[Fluvoxamine in the treatment of anxiety-depressive spectrum disorders].
Medvedev VE, Kardashian RA, Frolova VI.
Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(6):101-109. doi: 10.17116/jnevro2024124061101.
Current aspects of valproate in bipolar disorder.
Lennkh C, Simhandl C.
Int Clin Psychopharmacol. 2000 Jan;15(1):1-11. doi: 10.1097/00004850-200015010-00001.
Exposure to environmental chemicals and perinatal psychopathology.
Jacobson MH, Ghassabian A, Gore AC, Trasande L.
Biochem Pharmacol. 2022 Jan;195:114835. doi: 10.1016/j.bcp.2021.114835. Epub 2021 Nov 11.
Factor Structure of Cotard's Syndrome: Systematic Review of Case Reports.
Huarcaya-Victoria J, Bojórquez-De la Torre J, De la Cruz-Oré J.
Rev Colomb Psiquiatr (Engl Ed). 2020 Jul-Sep;49(3):187-193. doi: 10.1016/j.rcp.2018.10.008. Epub 2018 Dec 3.
